John Aballi - Nov 14, 2024 Form 4 Insider Report for EXAGEN INC. (XGN)

Role: President and CEO, Director
Signature: /s/ Jeffrey G. Black, as attorney-in-fact
Stock symbol: XGN
Transactions as of: Nov 14, 2024
Transactions value $: $68,297
Form type: 4
Date filed: 11/18/2024, 06:32 PM
Previous filing: May 16, 2024

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	XGN	Common Stock	Purchase	$68.3K	+24.3K	+3.65%	$2.81	690K	Nov 14, 2024	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.72 to $2.94, inclusive. The reporting person undertakes to provide Exagen Inc., any security holder of Exagen Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this form 4.

Content

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.72 to $2.94, inclusive. The reporting person undertakes to provide Exagen Inc., any security holder of Exagen Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this form 4.